Notebookcheck Logo
, , , , , ,
search relation.
, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,
 

Exciting non-invasive blood glucose monitor details promised by Afon for upcoming ATTD Conference

The Afon blood glucose (BG) monitor can be used with or without a smartwatch. (Image source: Afon - edited)
The Afon blood glucose (BG) monitor can be used with or without a smartwatch. (Image source: Afon - edited)
Afon Technology has once again taken to social media to announce exciting information about its work with a non-invasive blood glucose monitor wearable. Afon appears to be one of the leaders of the pack that is currently chasing the goal of producing a clinically approved and marketable non-invasive continuous glucose monitor (CGM).

Just recently, Afon took to Twitter to share news about its non-invasive blood glucose monitor. Along with stating in no uncertain terms that the wearable would be “coming soon”, the healthtech startup also revealed that tests had been very positive in terms of accuracy. Now it seems that it won’t be too much longer before those who are hopeful about the wearable monitor might learn even more specific details about the life-changing Afon device.

Apparently, Afon will be attending the Advanced Technologies & Treatments for Diabetes (ATTD) Conference, which is being held in Barcelona, Spain from 27 to 30 April. In addition, the company has made this bold statement: “we will be presenting exciting new data from our wearable, no-invasive [sic] blood glucose monitor”. The monitor is a needle-free solution that can either be worn as a sole wearable or as part of a smartwatch.

This momentum for Afon has been a long time coming; we reported about the wearable back in November of last year and work has been in progress on the specialist diabetes management device for long before that. Even in December 2019, Afon was hoping to have “a product on the market within 2 years”. Obviously, the COVID-19 pandemic slowed R&D at a global level for everyone, so it is understandable that there has been some delay.

Unfortunately, no projected cost for the Afon device has been made publicly available yet, but it could be comparatively economical due to the lack of requirement for part replacement. The ATTD attendance and new data promise demonstrates Afon’s supreme confidence in its blood glucose monitor, and it’s likely larger firms like Dexcom and Abbott will be keeping a watchful eye on what is about to be revealed by this Monmouthshire, Wales-based outfit.

Buy a Care Touch multi-colored diabetic lancet pack from Amazon

Source(s)

static version load dynamic
Loading Comments
Comment on this article
Daniel R Deakin
Daniel R Deakin - Managing Editor News - 2730 articles published on Notebookcheck since 2012
My interest in technology began after I was presented with an Atari 800XL home computer in the mid-1980s. I especially enjoy writing about technological advances, compelling rumors, and intriguing tech-related leaks. I have a degree in International Relations and Strategic Studies and count my family, reading, writing, and travel as the main passions of my life. I have been with Notebookcheck since 2012.
Please share our article, every link counts!
> Notebook / Laptop Reviews and News > News > News Archive > Newsarchive 2022 04 > Exciting non-invasive blood glucose monitor details promised by Afon for upcoming ATTD Conference
Daniel R Deakin, 2022-04- 9 (Update: 2022-04- 9)